Molecular Templates, Inc.
MTEM
MTEM was delisted on the 24th of December, 2024.
79 hedge funds and large institutions have $140M invested in Molecular Templates, Inc. in 2021 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 24 increasing their positions, 29 reducing their positions, and 18 closing their positions.
104% more call options, than puts
Call options by funds: $184K | Put options by funds: $90K
8% less funds holding
Funds holding: 86 → 79 (-7)
17% less repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 29
39% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 18
44% less capital invested
Capital invested by funds: $249M → $140M (-$109M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACP
Acuta Capital Partners
Redwood City,
California
|
+$1.61M |
| 2 |
BI
BVF Inc
San Francisco,
California
|
+$1.36M |
| 3 |
BlackRock
New York
|
+$1.14M |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
+$924K |
| 5 |
Walleye Capital
New York
|
+$776K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$6.04M |
| 2 |
WP
Woodline Partners
San Francisco,
California
|
-$3.33M |
| 3 |
ECM
Endurant Capital Management
San Mateo,
California
|
-$1.72M |
| 4 |
AIIC
AJU IB Investment Company
Seoul,
South Korea
|
-$1.37M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$709K |
MTEM Hedge Fund Activity: Q4 2021 in Review
79 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Molecular Templates, Inc. (MTEM) for Q4 2021, worth a combined $140M — down 44% from $249M a quarter earlier.
Sellers outnumbered buyers: 18 funds closed out of MTEM and 11 opened new positions — a net loss of 7 holders — while 29 trimmed existing stakes and 24 added.
The largest buyer was Acuta Capital Partners, opening a new position worth an estimated $1.61M. The largest seller was T. Rowe Price Associates, cutting an estimated $6.04M.
- 79 institutional investors held Molecular Templates, Inc. (MTEM) as of Q4 2021, down from 86 in Q3 2021.
- Funds reported $140M of Molecular Templates, Inc. stock for Q4 2021, down 44% quarter-over-quarter.
- 11 funds opened new Molecular Templates, Inc. positions in Q4 2021 and 18 closed out, a net change of -7 holders.
- The largest Molecular Templates, Inc. buyer in Q4 2021 was Acuta Capital Partners, an estimated $1.61M added.
- The largest Molecular Templates, Inc. seller in Q4 2021 was T. Rowe Price Associates, an estimated $6.04M sold.
Based on aggregated 13F filings for Q4 2021.